BioHealth News Archive

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow · BioBuzz

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow · BioBuzz

In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first of its kind…

Read More
MedImmune-lite? Immunocore delves into British Big Pharma’s R&D talent pool, again | FierceBiotech

MedImmune-lite? Immunocore delves into British Big Pharma’s R&D talent pool, again | FierceBiotech

Bahija Jallal, David Berman, Koustubh Ranadel, and now Mohammed Dar lines up as the latest AstraZeneca/MedImmune executive to jump ship into U.K. biotech Immunocore.…

Read More
Three Examples That Show Why NCI is a Goldmine of Blockbuster Technologies for Commercialization · BioBuzz

Three Examples That Show Why NCI is a Goldmine of Blockbuster Technologies for Commercialization · BioBuzz

What do the technologies that led to the success of Kite Pharma, the creation of the pioneering immune-oncology cancer treatment avelumab (BAVENCIOⓇ) and the…

Read More
Why Paragon Bioservices’ $1.2B acquisition deal matters to Baltimore – Technical.ly Baltimore

Why Paragon Bioservices’ $1.2B acquisition deal matters to Baltimore – Technical.ly Baltimore

For Paragon Bioservices, news came quickly earlier this month. On a Thursday in mid-April, Gov. Larry Hogan and other state and county officials joined…

Read More
FDA clears RemUnity drug pump co-developed by Deka, United Therapeutics

FDA clears RemUnity drug pump co-developed by Deka, United Therapeutics

United Therapeutics and Deka Research and Development have received FDA 510(k) clearance for the co-developed RemUnity system. The RemUnity system is a subcutaneous delivery…

Read More
With promising pivotal data, Viela Bio’s lead autoimmune drug heads for FDA filing – FierceBiotech

With promising pivotal data, Viela Bio’s lead autoimmune drug heads for FDA filing – FierceBiotech

Viela Bio spun out of AstraZeneca last year with six autoimmune and inflammation-aimed programs and $250 million. Now, the biotech is reporting positive pivotal…

Read More
FastForward exits show success of Hopkins incubator – Maryland Daily Record

FastForward exits show success of Hopkins incubator – Maryland Daily Record

Two years after Johns Hopkins Technology Ventures opened new office and lab space for its FastForward 1812 incubator on the Johns Hopkins Hospital campus,…

Read More
Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One – VentureBeat

Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One – VentureBeat

BrainScope announced today the publication of a study conducted by physicians at Washington University Barnes Jewish Medical Center in St. Louis in the peer-reviewed…

Read More
Project Onramp Meets Its Goal of Placing 50 Mass. Students from Low-Income Backgrounds into Summer Internships at Local Biotech Companies – Massachusetts Biotechnology Council

Project Onramp Meets Its Goal of Placing 50 Mass. Students from Low-Income Backgrounds into Summer Internships at Local Biotech Companies – Massachusetts Biotechnology Council

Project Onramp today announced they have placed more than 50 students in well-paid internships with top companies for summer 2019 through its first-in-the-nation Project…

Read More
Start-Ups Seeking Your Expertise

Start-Ups Seeking Your Expertise

Are you an experienced biohealth industry executive seeking full time or part time employment as a consultant or start-up C suite executive? BioHealth Innovation…

Read More
Computer science facility opens at University of Maryland

Computer science facility opens at University of Maryland

The University of Maryland has opened a 215,600-square-foot computer science facility on its College Park campus. The university says the Brendan Iribe Center for Computer…

Read More
Biotech runs on venture capital. But not all VC models are created equal – STAT

Biotech runs on venture capital. But not all VC models are created equal – STAT

Venture capital dollars are flooding into biotech, totaling $8.5 billion in 2017 alone. But there’s no one way to fund a startup. {iframe}https://www.statnews.com/2019/05/03/biotech-venture-capital-models/{/iframe}

Read More
First Annual Patenting Trends Study Provides Decision Makers With Clear and Actionable Information

First Annual Patenting Trends Study Provides Decision Makers With Clear and Actionable Information

Kilpatrick Townsend & Stockton and GreyB Services released today their findings from The First Annual Kilpatrick Townsend & GreyB Services Patenting Trends Study (Study). The Study provides…

Read More
Protenus Announces Former Chief Privacy Officer of HHS Office of the National Coordinator to Keynote 3rd Annual PANDAS Conference in Baltimore

Protenus Announces Former Chief Privacy Officer of HHS Office of the National Coordinator to Keynote 3rd Annual PANDAS Conference in Baltimore

The privacy and security of patient data continues to be increasingly important as access to this data increases and threats to this sensitive information…

Read More
Inside the biotech company hoping to solve medical mysteries

Inside the biotech company hoping to solve medical mysteries

The 3rd hour of TODAY looks at the Virginia-based biotech company Aperiomics, which says it has technology that could shake up health care and…

Read More